Beyond Screening: CRISPR as a Validation Tool

By Cambridge Alliance on Medicines Safety

A seminar by, Dr Paul Russell, Senior Scientist at Horizon Discovery Ltd. discussing the role of CRISPR in target validation.

Sales Ended